HELP LDL-apheresis in two cases of familial hypercholesterolemic pregnant women

Transfusion and Apheresis Science

Volumn 44, Issue 1, 2011, Pages 21-24

  Anedda, Sandra ^a   Mura, Silvia ^a   Marcello, Costantino ^a   Pintus, Paolo ^a  

^a BROTZU HOSPITAL   (Italy)

Author keywords

Autosomic recessive hypercholesterolemia; Coronary artery disease; Familial Hypercholesterolemia; Low density lipoprotein apheresis; Pregnancy

Indexed keywords

ATENOLOL; EZETIMIBE; HEPARIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ANION EXCHANGE RESIN; METHYLDOPA; STEROID;

ADULT; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEPARIN INDUCED EXTRACORPOREAL LIPOPROTEIN PRECIPITATION THERAPY; HUMAN; HYPERLIPOPROTEINEMIA; HYPOTENSION; PLASMAPHERESIS; PREGNANT WOMAN; TREATMENT OUTCOME; APHERESIS; HEPARIN INDUCED EXTRACORPOREAL LIPOPROTEIN PRECIPITATION; HYPERTENSION; PLASMA VISCOSITY; RESPIRATORY DISTRESS; TRANSLUMINAL CORONARY ANGIOPLASTY; ULTRAFILTRATION;

ADSORPTION; ADULT; BLOOD COMPONENT REMOVAL; CESAREAN SECTION; CHEMICAL PRECIPITATION; CHROMATOGRAPHY, ION EXCHANGE; CORONARY DISEASE; EXTRACORPOREAL CIRCULATION; FEMALE; HEPARIN; HETEROZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; HYPOLIPIDEMIC AGENTS; INFANT, NEWBORN; LIPOPROTEINS, LDL; POLYCARBOXYLATE CEMENT; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY, HIGH-RISK; ULTRAFILTRATION;

EID: 79951680183     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2010.12.004     Document Type: Article

References (32)

1. Amundsen A.L., Khoury J., Iversen P.O., Bergei C., Ose L., Tonstad S., et al. Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia. Atherosclerosis 2006, 189(2):451-457.
2. Belo L., Caslake M., Santos-Silva A., Castro E.M., Pereira-Leite L., Quintanilha A., et al. LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study. Atherosclerosis 2004, 177(2):391-399.
3. Belo L., Caslake M., Gaffney D., Santos-Silva A., Pereira-Leite L., Quintanilha A., et al. Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis 2002, 162(2):425-432.
4. Kroon A.A., Swinkels D.W., van Dongen P.W., Stalenhoef A.F. Pregnancy in a patient with homozygous familial hypercholesterolemia treated with long-term low-density lipoprotein apheresis. Metabolism 1994, 43(9):1164-1170.
5. Teruel J.L., Lasunción M.A., Navarro J.F., Carrero P., Ortuño J. Pregnancy in a patient with homozygous familial hypercholesterolemia undergoing low-density lipoprotein apheresis by dextran sulfate adsorption. Metabolism 1995, 44(7):929-933.
6. Cashin-Hemphill L., Noone M., Abbott J.F., Waksmonski C.A., Lees R.S. Low-density lipoprotein apheresis therapy during pregnancy. Am J Cardiol 2000, 86(10):1160. A10.
7. Dittrich E., Schmaldienst S., Langer M., Jansen M., Hörl W.H., Derfler K. Immunoadsorption and plasma exchange in pregnancy. Kidney Blood Press Res 2002, 25(4):232-239.
8. Schlienger J.L., Brignon P., Grunenberger F. Treatment by LDL-apheresis during pregnancy. Presse Med 2003, 32(13 Pt 1):603.
9. Klingel R., Göhlen B., Schwarting A., Himmelsbach F., Straube R. Differential indication of lipoprotein apheresis during pregnancy. Ther Apher Dial 2003, 7(3):359-364.
10. Makino H., Harada-Shiba M. Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia. Ther Apher Dial 2003, 7(4):397-401.
11. Wang Y., Walli A.K., Schulze A., Blessing F., Fraunberger P., Thaler C., et al. Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia. Transfus Apher Sci 2006, 35(2):103-110.
12. Ertorer M.E., Guvenc B., Haydardedeoglu B., Tekinturhan F. A case report of the cascade filtration system: a safe and effective method for low-density lipoprotein apheresis during pregnancy. Ther Apher Dial 2008, 12(5):396-400.
13. Khoury J., Amundsen A.L., Tonstad S., Henriksen T., Ose L., Retterstøl K., et al. Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia. Acta Obstet Gynecol Scand 2009, 88(2):222-226.
14. Biri A., Bozkurt N., Turp A., Kavutcu M., Himmetoglu O., Durak I. Role of oxidative stress in intrauterine growth restriction. Gynecol Obstet Invest 2007, 64(4):187-192.
15. Lefèvre G., Berkane N., Uzan S., Etienne J. Pre-eclampsia and oxygenated free radicals. Ann Biol Clin (Paris) 1997, 55(5):443-450.
16. Cekmen M.B., Erbagci A.B., Balat A., Duman C., Maral H., Ergen K., et al. Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension. Clin Biochem 2003, 36(7):575-578.
17. Llurba E., Gratacós E., Martín-Gallán P., Cabero L., Dominguez C. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med 2004, 37(4):557-570.
18. Bayhan G., Koçyigit Y., Atamer A., Atamer Y., Akkus Z. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia. Gynecol Endocrinol 2005, 21(1):1-6.
19. Adiga U., D'souza V., Kamath A., Mangalore N. Antioxidant activity and lipid peroxidation in preeclampsia. J Chin Med Assoc 2007, 70(10):435-438.
20. Gupta S., Agarwal A., Sharma R.K. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv 2005, 60(12):807-816.
21. Liguori A., D'Armiento F.P., Palagiano A., Balestrieri M.L., Williams-Ignarro S., de Nigris F., et al. Effect of gestational hypercholesterolaemia on omental vasoreactivity, placental enzyme activity and transplacental passage of normal and oxidised fatty acids. BJOG 2007, 114(12):1547-1556.
22. Avis H.J., Hutten B.A., Twickler M.T., Kastelein J.J., van der Post J.A., Stalenhoef A.F., et al. Pregnancy in women suffering from familial hypercholesterolemia: a harmful period for both mother and newborn?. Curr Opin Lipidol 2009.
23. Palinski W., Nicolaides E., Liguori A., Napoli C. Influence of maternal dysmetabolic conditions during pregnancy on cardiovascular disease. J Cardiovasc Transl Res 2009, 2(3):277-285.
24. Alkemade F.E., Gittenberger-de Groot A.C., Schiel A.E., VanMunsteren J.C., Hogers B., van Vliet L.S., et al. Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life. Arterioscler Thromb Vasc Biol 2007, 27(10):2228-2235.
25. Dukić A., Zivancević-Simonović S., Varjacić M., Dukić S. Hyperlipidemia and pregnancy. Med Pregl 2009, 62(Suppl. 3):80-84.
26. Goldstein J.L., Brown M.S. Familial Hypercholesterolemia. The metabolic basis of inherited disease 1989, 1195-1250. Mc Graw-Hill Book Co., New York. 5th ed.
27. Russel D.W., Esser V., Hobbs H.H. Molecular basis of familial hypercholesterolemia. Atherosclerosis 1989, 9(Suppl. 1):8-13.
28. Ciccarese M., Pacifico A., Tonolo G., Pintus P., Nikoshkov A., Zuliani G., et al. A new locus for autosomal recessive hypercholesterolemia maps to human chromosome 15q25-q26. Am J Hum Genet 2000, 66(2):453-460.
29. Arca M., Zuliani G., Wilund K., Campagna F., Fellin R., Bertolini S., et al. Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis. Lancet 2002, 359(9309):841-847.
30. Filigheddu F., Quagliarini F., Campagna F., Secci T., Degortes S., Zaninello R., et al. Arca M Prevalence and clinical features of heterozygous carriers of autosomal recessive hypercholesterolemia in Sardinia. Atherosclerosis 2009.
31. Seidel D., Armstrong V.W., Schuff-Werner P., Eisenhauer T. Removal of low-density lipoproteins (LDL) and fibrinogen by precipitation with heparin at low pH clinical application and experience. J Clin Apheresis 1988, 4:78-81.
32. Wang Y., Blessing F., Walli A.K., Uberfuhr P., Fraunberger P., Seidel D. Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins-reduction of circulating proinflammatory and procoagulatory markers. Atherosclerosis 2004, 175(1):145-150.